United States v. Buchanan

District Court, District of Columbia·Decided April 14, 2025·No. Criminal No. 2024-0256·Published

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA

UNITED STATES OF AMERICA v.

Criminal Action No. 24-256 (CKK)

KEVIN BRENT BUCHANAN,

Defendant.

MEMORANDUM OPINION

(April 14, 2025)

A grand jury has indicted Kevin Brent Buchanan on three counts of making threatening interstate communications, in violation of 18 U.S.C. § 875(c). See Superseding Indictment, ECF No. 25. Buchanan’s case is set for trial beginning in July 2025. See Am. Pretrial Scheduling Order, ECF No. 40. Now pending before the Court is the Government’s [47] Motion in Limine requesting an order precluding Buchanan from offering evidence or argument at trial in support of a diminished capacity defense (“Motion” or “Gov’t’s Mot.”). Buchanan opposes the Motion. See Def.’s Opp’n to the Gov’t’s Mot. in Limine (“Def.’s Opp’n”), ECF No. 49. Upon consideration of the parties’ submissions,1 the relevant legal authority, and the entire record, the Court shall GRANT IN PART, DENY IN PART, and HOLD IN ABEYANCE IN PART the Government’s Motion.2 Specifically, the Court shall preclude Buchanan’s proffered expert witness from opining

1 The Court’s consideration has focused on the following documents:

• Defendant Buchanan’s Expert Witness and Lay Opinion Designation (“Def.’s Designation”), ECF No. 47-1;

• The Government’s Motion in Limine to Preclude Defendant’s Proposed Evidence and Argument in Support of a Diminished Capacity Defense (“Gov’t’s Mot.”), ECF No. 47;

• Defendant Buchanan’s Opposition to the Government’s Motion in Limine (“Def.’s Opp’n”), ECF No. 49;

and

• The Government’s Reply in Support of its Motion in Limine to Preclude Defendant’s Proposed Evidence and Argument in Support of a Diminished Capacity Defense (“Gov’t’s Reply”), ECF No. 50.

2 The Court expresses no view at this time on the Government’s recent [51] Omnibus Motion in Limine, which is not yet ripe for decision.

on the ultimate issue of whether Buchanan had the mental state necessary to commit the crimes charged. The Court shall also order Buchanan to produce a revised Rule 16(b)(1)(C) expert disclosure statement specifying the scope of and basis for any other expert opinion that his proffered expert witness may present to the jury. And the Court shall set an evidentiary hearing to evaluate the proffered expert witness’s qualifications and the scope of and basis for any potentially admissible expert witness testimony. Finally, the Court shall allow Buchanan to introduce lay witness opinion testimony that is relevant to whether he was conscious of wrongdoing at the time of the alleged acts for which he is charged in this case, provided that such testimony must be rationally based on each witness’s own perception. The Court shall otherwise defer ruling on the Government’s Motion until the relevant issues arise at the forthcoming evidentiary hearing or at trial.

I. BACKGROUND

The Government alleges that, over the course of three days beginning in late October 2023, Buchanan left five threatening voicemails for an organization—known in this case as “Organization 1”—that is headquartered in this District. See Gov’t’s’ Mot., ECF No. 47, at 1–2; Superseding Indictment, ECF No. 25. The Government alleges that Buchanan recorded these voicemails from Utah. See Superseding Indictment ¶¶ 4, 6, 8. It further alleges that Buchanan selected Organization 1 as the object of his threatening messages based on “race, color, religion, national origin, and ethnicity.” Id. ¶ 10.

For this alleged conduct, a grand jury charged Buchanan by superseding indictment with three counts of making threatening interstate communications, in violation of 18 U.S.C. § 875(c), enhanced by a special finding that Buchanan selected the “object of the offense[s]” because of one or more protected characteristics. See Superseding Indictment ¶¶ 4, 6, 8, 10.

In anticipation of trial on these charges, Buchanan has designated Dr. Glen E. Johnson, M.D., as an expert witness in his defense. See Def.’s Designation, ECF No. 47-1, at 1–2. Dr. Johnson is a board-certified psychiatrist who has been working in private practice in Utah since 1978. Id. at 4. In a letter filed alongside Buchanan’s expert disclosure statement, Dr. Johnson represents that he has been working with Buchanan since 2014. Id. at 6. But see id. (stating, as of March 2024, that Dr. Johnson had been working with Buchanan “for seven years”). Dr. Johnson also reports that Buchanan has been diagnosed with severe post-traumatic stress disorder and recurring panic disorder. Id. Buchanan is receiving ongoing treatment for these conditions, which Dr. Johnson says render him “functionally disabled.” Id.

Buchanan proffers that, if allowed to testify at trial, Dr. Johnson would:

explain that Mr. Buchanan’s diagnoses of chronic post-traumatic stress disorder, as well as panic disorder with anger susceptibility to undefined stress and uncertainty, mean that Mr. Buchanan is prone to react reflexively and with poor impulse control.

This means that, to a reasonable degree of medical and scientific probability, when he contacted the organization in question, he likely was unable to formulate the requisite specific intent to violate the statutes pursuant to which he is charged in the indictment.

Id. at 1–2. In the letter accompanying Buchanan’s expert disclosure statement, Dr. Johnson also states that Buchanan “has never demonstrated any violence” or “following through with threats,” and he “poses no risk to anyone.” Id. at 6. Dr. Johnson also asserts that Buchanan’s actions giving rise to this case were “secondary to his medical illness” and a response to “a scam call” that Buchanan had received that “trigger[ed] strong feeling regarding Palestinians.” Id. Buchanan has not submitted an expert report from Dr. Johnson, and neither his expert disclosure notice nor the accompanying attachments clearly set out the bases and reasons for Dr. Johnson’s opinions. See id. at 1–8.

Buchanan has also given notice that he intends to elicit lay opinion witness testimony from people who know him well, including members of his family, to the effect that “he is impulsive, quick to anger, with little self-control when he feels provoked” and that he “otherwise exhibits the symptoms observed by Dr. Johnson.” See Def.’s Designation at 3.

The Government now seeks an order precluding Buchanan from introducing evidence or argument in support of a diminished capacity defense. See Gov’t’s Mot. at 1. Buchanan opposes the Government’s request. See Def.’s Opp’n at 2.

II. LEGAL STANDARDS

A. Opinion Testimony Federal Rule of Evidence 702 allows opinion testimony from “[a] witness who is qualified as an expert by knowledge, skill, experience, training, or education” if, among other conditions, the witness’s specialized knowledge “will help the trier of fact to understand the evidence or to determine a fact in issue.” Fed. R. Evid. 702. To be admissible, expert witness testimony must be relevant, reliable, and based in “scientific knowledge.” Daubert v. Merrell Dow Pharms., Inc., 509 U.S. 579, 589 (1993). The proponent of expert witness testimony bears the burden of establishing the witness’s qualifications and the admissibility of the testimony. United States v. McGill, 815 F.3d 846, 903 (D.C. Cir. 2016).

A separate rule, Federal Rule of Evidence 701, allows a lay witness to testify in the form of an opinion if the opinion is “rationally based on the witness’s perception,” “helpful to clearly understanding the witness’s testimony or to determining a fact in issue,” and not based on the kind of specialized knowledge that forms the basis of expert opinion testimony. Fed. R. Evid. 701.

Free access — add to your briefcase to read the full text and ask questions with AI

United States v. Buchanan, (D.D.C. 2025).

United States v. Buchanan (United States v. Buchanan) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Morissette v. United States
342 U.S. 246 (Supreme Court, 1952)
Watts v. United States
394 U.S. 705 (Supreme Court, 1969)
Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Kumho Tire Co. v. Carmichael
526 U.S. 137 (Supreme Court, 1999)
United States v. Smith
640 F.3d 358 (D.C. Circuit, 2011)
United States v. Pohlot, Stephen
827 F.2d 889 (Third Circuit, 1987)
United States v. Karen Cameron
907 F.2d 1051 (Eleventh Circuit, 1990)
United States v. Willie George Childress
58 F.3d 693 (D.C. Circuit, 1995)
United States v. Syring
522 F. Supp. 2d 125 (District of Columbia, 2007)
United States v. Gold
661 F. Supp. 1127 (District of Columbia, 1987)
United States v. Davis
78 F. Supp. 3d 17 (District of Columbia, 2015)
Elonis v. United States
575 U.S. 723 (Supreme Court, 2015)
United States v. Keith McGill
815 F.3d 846 (D.C. Circuit, 2016)
Voisine v. United States
579 U.S. 686 (Supreme Court, 2016)
United States v. Sherri Davis
863 F.3d 894 (D.C. Circuit, 2017)
Manis v. Erwin Utilities
661 F. Supp. 3 (E.D. Tennessee, 1986)
Counterman v. Colorado
600 U.S. 66 (Supreme Court, 2023)
Diaz v. United States
602 U.S. 526 (Supreme Court, 2024)